Tony Perez Chief Health Sciences Counsel University of California, San Diego (formerly Director, IRB Administration University of California, Davis) Measure IRB Approval Process Establish Common Milestones Define Milestones ◦ When has milestone been achieved? Measurement Understanding of Variables Affecting Milestone Achievement • Variables Influencing Achievement – Complexity of Protocol – Receipt of Documents From Sponsor – Complexity of IRB Application Form – Assistance from IRB or Other Office • Clinical Trials Office • IRB Administration Office – PI Staffing • Competence • Amount Variables Influencing Achievement ◦ Administrative Approval Administration Sign-off Resource Sign-off ◦ Other Required Approvals Scientific Review Committee Radiation Use Committee • Variables Influencing Achievement – Workload of IRB Administration • Administrative Pre-Review for Completeness • Substantive Pre-Review – Response of PI to Correct Submission Deficiencies – Response of Sponsor to Correct Submission Deficiencies – Workload of IRB • Overworked IRB Members • Lack of IRB Members Variables Influencing Achievement ◦ Workload of IRB Members Large Volume of Protocols to Review Large Volume of Revisions to Review ◦ Workload of IRB Committees Limitations on Meeting Agenda Items Other Items to Review Substantive Modifications Unanticipated Problems Variables Influencing Achievement ◦ ◦ ◦ ◦ Workload in IRB Administration Office Expertise of IRB Administration Staff Clarity of Requests by IRB Members Method of Transmission Variables Influencing Achievement ◦ Volume of Required Revisions ◦ Complexity of Required Revisions ◦ Communication with and Approval from Sponsor Variables Influencing Achievement ◦ Workload of IRB Administration Office ◦ Method of Transmission Quantitative Analysis of HRPP Workflow Michael Caligiuri, Ph.D. Director, HRPP UCSD June, 2008 Time Period: IRB Review to Final Approval 4 biomedical committees; randomly assigned a code number Independent variables (project characteristics): Dates of Correspondence Vulnerable populations Initial Review Status Risk level (0-4)* Cancer Trial Renewal Funding Device Study PI Department Radiation Use of DNA VA *0=surveys, chart reviews; 1=observational; 2=minimal risk, blood draw, vulnerable population; 3=Phase III, investigational drug or device; 4=Phase I or II safety trial 20 18 Mean = 37.2 days Median = 27 days 16 14 12 10 8 Number of Projects 6 4 2 0 0 10 20 30 40 50 60 70 80 Total Time, days 90 100 110 120 30 28 PI 26 Mean PI time: 19.97 ± 21.7 days 24 22 20 18 16 14 12 Number of Protocols 10 8 6 4 2 0 -10 0 10 20 30 40 50 60 70 80 Number of Days with PI 90 100 35 30 HRPP 25 Mean HRPP time: 19.86 ± 15.9 days 20 15 Number of Protocols 10 5 0 -10 0 10 20 30 40 50 60 Number of Days with HRPP 70 80 90 y = 8.24 - 0.2 * x 80 60 3 weeks 40 20 0 -20 HRPP Time - PI Time, -40 -60 -80 -20 0 20 40 60 80 Total Approval Time, days 100 120 140 Predictive Models Model 1: 3 factors Committee, Funding, Radiation Statistic: F=4.33; p<0.01 Test 1: C=1; F=C; R=No 67 days C=2; F=C; R=No 59 days C=3; F=C; R=No 51 days Conclusion: Committee assignment accounts for 8 days Predictive Models Model 1: 3 factors Committee, Funding, Radiation Statistic: F=4.33; p<0.01 Test 2: C=1; F=C; R=No 67 days C=1; F=NC; R=No 49 days Conclusion: Funding source accounts for 18 days Impact of Funding Source on Approval Delays for each Biomedical IRB 140 120 100 80 60 40 Total Time for Approval, in da 20 0 -20 1 2 3 Committee 4 Fed Com Impact of Radiation Exposure and PRMC Review on Approval Delays for each Biomedical IRB 110 100 90 80 No PRMC review 70 60 50 40 30 Total Time for Approval, in days 20 10 0 -10 1 2 3 Committee 4 No Rad Rad Tony Perez, J.D. Chief Health Sciences Counsel University of California, San Diego University Center 201 9500 Gilman Drive #0097 La Jolla, California 92093-0097 (858) 246-0222 tonyperez@ucsd.edu Michael Caligiuri, Ph.D. Director, Human Research Protections Program University of California, San Diego La Jolla Village Professional Center Suite A208 8950 Villa La Jolla La Jolla, California 92037 Phone: 858-455-5050 mcaligiuri@ucsd.edu